A respected provider of technology and equipment for medicinal and analytical chemistry.

This content is normally republished with kind authorization from our friends at The Kaiser Family members Foundation. You can view the complete Kaiser Daily Health Plan Record, search the archives, or sign up for email delivery of in-depth coverage of wellness policy developments, debates and discussions. The Kaiser Daily Health Policy Report is released for Kaisernetwork.org, a free of charge program of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Board Firm and Kaiser Family Foundation. All rights reserved.. Biotage launches Isolera ELSD-1080 evaporative light-scattering detector for flash purification Biotage , a respected provider of technology and equipment for medicinal and analytical chemistry, announced the start of the Isolera ELSD-1080 evaporative light-scattering detector for flash purification.The clinical results are in keeping with the preclinical results that BIND-014 concentrates medication activity in the tumor leading to improved efficacy. We are very happy with these data as our ongoing medical study with BIND-014 lays a solid foundation to progress into Phase 2 advancement later this year. Furthermore, these data display the emerging potential of BIND-014 to become a significant new tumor therapy for sufferers by fundamentally changing the pharmacology of docetaxel and can concentrate in the tumors by up to ten-fold differentially, as shown in our preclinical versions, for better medical efficacy across multiple cancers including those where regular docetaxel has minimal activity, stated Scott Minick, Chief and President Executive Officer of BIND Biosciences.

Other articles from category "alternative medicine":

Random articles